SynBioBeta Speaker
Jason T. Gammack
Ansa Biotechnologies
CEO
With over 25 years of experience in the life science and molecular diagnostic industry, I am a founder, investor, and advisor who helps innovative biotech companies achieve their full potential. I am currently the founder and managing director of JTG Investments & Advisory UG, a firm that provides strategic and financial guidance to emerging and established biotech companies in Europe and the US. Previously, I was the co-founder and CEO of Resolve BioSciences, a company that developed a revolutionary technology for spatial omics and single-cell analysis. I led the company from inception to acquisition, securing multiple rounds of funding, building a strong team, and launching the first product in the market. I also held senior executive roles at Inscripta, QIAGEN, Ingenuity Systems, and Affymetrix, where I drove the commercialization of disruptive life science tools and solutions, from concept to market ownership. I have a proven track record of increasing sales and growing the bottom line, while spearheading operational improvements and marketing strategies. I am passionate about bringing cutting-edge technologies and solutions to the life science research and clinical communities, and enabling them to advance scientific discovery and improve human health. I am an inspirational leader and dynamic storyteller who clearly articulates the vision and value proposition of the business, and empowers the team to achieve success. I excel in dynamic, demanding environments, while remaining pragmatic and focused. I am always looking for new opportunities and challenges to leverage my expertise and network, and to make a positive impact in the biotech sector.
